DnB Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $5.89M | Sell |
|
|||||
|
2021
Q1 | $151M | Buy |
|
|||||
|
2020
Q4 | $44.9M | Buy |
|
|||||
|
2020
Q3 | $11.5M | Sell |
|
|||||
|
2020
Q2 | $84M | Sell |
|
|||||
|
2020
Q1 | $69.7M | Buy |
|
|||||
|
2019
Q4 | $3.91M | Sell |
|
|||||
|
2019
Q3 | $4.65M | Buy |
|
|||||
|
2019
Q2 | $5.93M | Buy |
|
|||||
|
2019
Q1 | $4.58M | Buy |
|
|||||
|
2018
Q4 | $2.52M | Sell |
|
|||||
|
2018
Q3 | $3.78M | Buy |
|
|||||
|
2018
Q2 | $3.25M | Buy |
|
|||||
|
2018
Q1 | $2.8M | Buy |
|
|||||
|
2017
Q4 | $2.73M | Hold |
|
|||||
|
2017
Q3 | $3.2M | Hold |
|
|||||
|
2017
Q2 | $2.78M | Sell |
|
|||||
|
2017
Q1 | $2.84M | Buy |
|
|||||
|
2016
Q4 | $2.61M | Sell |
|
|||||
|
2016
Q3 | $3.66M | Buy |
|
|||||
|
2016
Q2 | $2.31M | Buy |
|
|||||
|
2016
Q1 | $2.65M | Buy |
|
|||||
|
2015
Q4 | $2.16M | Sell |
|
|||||
|
2015
Q3 | $1.8M | Buy |
|
|||||
|
2015
Q2 | $1.95M | Hold |
|
|||||
|
2015
Q1 | $1.87M | Sell |
|
|||||
|
2014
Q4 | $2.06M | Buy |
|
|||||
|
2014
Q3 | $1.66M | Buy |
|